She told me via email that her device "might work" for non-somatic tinnitus patients. But she is not sure. Noise-induced tinnitus can have a somatic component too.
Mine is non-somatic anyway... I'm more focused on Lenire but any progress is welcome.
I really don't care in the end if people file into camp Shore vs. Neuromod although I struggle to accept the logic behind favoring her device other than the
"academia = good, capitalism = bad" ideology.
The first post in this thread goes all the way back to 2013. If she's so big on research, why should she be limited to saying her device
"might work" for bog standard noise-induced tinnitus? Why would we be able to point to so few test subjects? What else has she been doing with her time these last 7 years that has kept her from running more trials? She's had more than enough time to
find out if it works for non-somatic patients.
This is why I accused her of being the sloth from Zootopia. Her now starting to run more trials and pivot towards commercialization in 2019 is all well and good, but it doesn't change the looong timeframe where things seemed to be moving at a snail's pace, and it leaves people wondering how effective it might really be given the lack of test data vs. Neuromod.
So again, I don't understand why people think her device will be more effective. Sure, she's an academic, and maybe they've spent years tweaking the device, but where is the test data to show for all that so-called refinement?
Neuromod, in the PowerPoint presentation, demonstrated that they've been iterating rapidly to try to improve efficacy since Hubert Lim joined the team. So it's not like they stopped researching either.
If you want to point to a rival to Lenire coming out of academia, the
device from University of Minnesota seems more promising to me, because we have someone here who was on that trial with bog standard tinnitus who was helped greatly by it. That project also seems to be moving slowly and doesn't have a ton of test subjects but it at least seems to be the real deal.